We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+783.94%
AUM
$536M
AUM Growth
+$15.7M
Cap. Flow
+$15.8M
Cap. Flow %
2.95%
Top 10 Hldgs %
33.47%
Holding
130
New
25
Increased
35
Reduced
45
Closed
12

Top Sells

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$6.77M
2
GILD icon
Gilead Sciences
GILD
+$6.57M
3
DIS icon
Walt Disney
DIS
+$5.6M
4
APTV icon
Aptiv
APTV
+$4.77M
5
AMGN icon
Amgen
AMGN
+$4.22M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Healthcare 17.09%
3 Industrials 15.79%
4 Financials 13.49%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
126
The Mosaic Company
MOS
$7.42B
-15,518
Closed -$416K
OGN icon
127
Organon & Co
OGN
$3.56B
-353,832
Closed -$6.77M
SQQQ icon
128
ProShares UltraPro Short QQQ
SQQQ
$1.75B
-1,180
Closed -$218K
WPC icon
129
W.P. Carey
WPC
$16.4B
-3,301
Closed -$206K
XLF icon
130
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
-8,795
Closed -$399K

Similar funds

Bourgeon Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bourgeon Capital Management held 130 positions worth $536M, up 3% from $520M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bourgeon Capital Management's Q4 2024 filing shows 25 new, 35 increased, 45 reduced and 12 closed positions. Its largest new stake was EQT Corp: 208,251 shares worth $9.6M. The largest sale was Organon & Co, an estimated $6.77M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Bourgeon Capital Management's largest Q4 2024 buy was EQT Corp: 208,251 shares worth $9.6M.
  • Bourgeon Capital Management added most to Pfizer in Q4 2024, an estimated $9.76M increase.
  • Bourgeon Capital Management's biggest Q4 2024 reduction was Amgen, cutting an estimated $4.22M.
  • Bourgeon Capital Management fully exited Organon & Co in Q4 2024, selling an estimated $6.77M.
  • Bourgeon Capital Management's ten largest holdings make up 33% of its $536M portfolio in Q4 2024.
  • Bourgeon Capital Management opened 25 new positions and closed 12 in Q4 2024.
  • Bourgeon Capital Management's portfolio value rose 3% quarter-over-quarter to $536M.

Based on Bourgeon Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.